AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LEXINGTON, Mass., Sept. 3, 2013 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that William Heiden, AMAG’s chief executive officer, will participate in two upcoming investor conferences. The sessions will include a brief company presentation followed by a question and answer session, in which the company’s business, strategy and growth prospects will be discussed.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC